Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 19Neoplasms 2Neoplasm Metastasis 2Urogenital Neoplasms 1Prostatic Diseases 1Neoplasms, Glandular and Epithelial 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Metastatic Castrate-resistant Prostate Cancer 1Genital Neoplasms, Male 1Carcinoma 1Adenocarcinoma 1

Interventions

padeliporfin 2Paclitaxel 2sipuleucel-T 1pembrolizumab 1luprolide acetate gel depot 1ixabepilone 1Therapeutics 1Suspensions 1Powders 1Pluvicto 1Nivolumab 1Leuprolide 1Ipilimumab 1Imatinib Mesylate 1Gemcitabine 1Cisplatin 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Genital Neoplasms, Male × sipuleucel-T × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡